Cassava Sciences’ experimental Alzheimer’s drug simufilam is currently in clinical trials. Meanwhile, the company is experiencing a major shake-up. Its CEO and lead neuroscientist…
It’s been a big year for Alzheimer’s research. Between July 6 of last year and this July 2, two disease-modifying drugs for Alzheimer’s disease received full…
Dementia can be tough for young family members to get their heads around. Here are six pieces of guidance from children’s book authors who’ve…
A new drug for Alzheimer’s was just this month approved by the FDA for use in the United States, in people in the earliest…
Regular physical activity can improve cardiovascular and brain health, especially for those worried about Alzheimer’s risk. And for people who may already be living…
Have you ever thought about donating your brain to science? Don’t worry — I mean after you die. Perhaps you’ve heard about donating your…
Human beings have always been fascinated by the brain. Although scientific knowledge about this 1.3 kg of fragile substance embedded in our cranium has…
By a woman’s late 40s, there is a good chance she’ll have started to experience the early phases of menopause. Menopause isn’t just the…
It can be challenging to find information about Alzheimer’s clinical trials, let alone find trial participants’ first-hand accounts of their experiences. People living with…
There are more than 500 active clinical trials for Alzheimer’s and other dementias in the U.S. They are designed to test different interventions, such…
Clinical trials and studies scientific experiments that investigate new treatments, lifestyle interventions, or risk factors for developing a disease like Alzheimer’s or dementia. By…
Climate change is making the symptoms of certain brain conditions worse, our new review has found. Conditions that can worsen as temperature and humidity…
Dementia can be anxiety-provoking for both the people living with it and their loved ones and caretakers. People new to caregiving or to neurodegenerative…
UPDATED JULY 3: The Food and Drug Administration has approved Kisunla (generic name donanemab), a new Alzheimer’s drug developed by Eli Lilly. The published data…
A new anti-amyloid drug for Alzheimer’s disease might receive FDA approval as soon as this month. Although anti-amyloid drugs have shown us that clear…